First, we're opening up our network to everyone, and working over the coming months and years to get as many providers in-network as possible
Safety Considerations and Monitoring for Young Adults on GLP-1s GLP-1 medications are generally well-tolerated, but nausea, vomiting, and constipation occur commonly during dose initiation and escalation
Users typically notice improvements in digestion within 24 to 72 hours, with more substantial changes, such as better regularity and increased energy, occurring within two to four weeks of consistent use
However, because Retatrutide remains a pre-approval research compound in the UK, supply must be correctly positioned for laboratory use only
We want to make sure weve really thought about everything. Right now, the criteria for receiving a GLP-1 prescription are primarily related to obesity, diabetes, cardiovascular disease, obstructive sleep apnea and metabolic dysfunction-associated steatohepatitis, among other things not for mental or behavioral health conditions